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Deep dentinal caries are frequently associated with
enhanced pulp vascularization. The initial hemodynamic
changes in the capillary and venous network are vaso-
dilatation and increased vascular permeability within the
pulp tissue (1). Absorption of interstitial fluid back into
the vessels, increased lymph flow, and opening of arte-
riovenous anastomosis are mechanisms used by the pulp
tissue to maintain intrapulpal pressure (2). However, the
dental pulp tissue is confined within rigid walls (3) and
the pulp tissue pressure tends to increase when it is
exposed to continuous noxious stimuli, such as caries.
When the intrapulpal pressure passes an unknown
threshold, and the local pressure-relief mechanisms are
no longer effective, irreversible pulp inflammation or
necrosis may occur (4).
The most common cause of pulpitis is cariogenic
bacteria and their products (5). Gram-positive bacteria
such as Streptococci, Lactobacilli, and several Gram-
positive rods have been found in carious dentin (6). In
the presence of sucrose, caries-related Gram-positive
bacteria produce large quantities of lipoteichoic acid (7),
an amphiphilic molecule anchored to the bacterial cell
wall that has been implicated in inflammation (8). Gram-
negative bacteria such as Prevotella and Porphyromonas
have also been found in teeth with dentinal caries and
symptoms of reversible pulpitis (9–11), and in teeth with
deep caries and/or pulp exposure with irreversible pulp-
itis (12). These bacteria play a significant role in the
development of clinical symptoms through the produc-
tion of pro-inflammatory cytokines such as interleukin
(IL)-1b (13), IL-6 (14), and IL-8 (15). In contrast to the
lipoteichoic acid found in Gram-positive bacteria, the
cell wall of Gram-negative bacteria contains lipopoly-
saccharides (LPS). Lipopolysaccharide is a heat-stable
molecule composed of polysaccharides and phospholi-
pids. The hydrophobic component of LPS (lipid A) is
embedded in the bacterial cell wall and determines the
endotoxin properties of this molecule such as toxicity,
pyrogenicity, and macrophage and complement activa-
tion (16). The rough core polysaccharide side-chain in
the center and the O-antigenic side chain in the periph-
eral area determine serotype specificity (17). The signa-
ling events triggered by LPS in mammalian cells are
believed to be initiated upon its binding to a cell surface
receptor CD14 (18, 19), or to Toll-like receptors (TLRs),
primarily TLR-4 and its accessory protein MD2 (20).
Activation of these receptors initiates several intracellu-
lar signaling pathways that involve MyD88, I-j B kinase
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Vascular endothelial growth factor (VEGF), a potent pro-angiogenic factor, might
regulate the neovascularization observed in the pulp of teeth with deep caries. The
purpose of this in vitro study was to evaluate the effect of bacterial lipopolysaccharides
(LPS) on VEGF expression in dental pulp cells. Mouse odontoblast-like cells (MDPC-
23) or undifferentiated pulp cells (OD-21) were exposed to 0–20 lg ml)1 Escherichia
coli LPS or 0–80 lg ml)1 Prevotella intermedia LPS. As controls, mouse macrophages
or gingival fibroblasts were exposed to LPS, since these cells are known to secrete
VEGF. The VEGF expression was evaluated by reverse transcriptase polymerase
chain reaction or enzyme-linked immunosorbent assay. The baseline expression levels
of VEGF protein were higher in MDPC-23 and OD-21 than in fibroblasts or macr-
ophages. Vascular endothelial growth factor protein expression was upregulated in
MDPC-23 and macrophages exposed to E. coli LPS, but not in OD-21 cells or
fibroblasts. Higher concentrations of P. intermedia LPS were required to induce
VEGF expression in MDPC-23 cells. Treatment with LPS did not affect VEGF ex-
pression at the mRNA level in any of the cells evaluated. These results demonstrate
that bacterial LPS upregulates VEGF expression in odontoblast-like cells and macr-
ophages, and suggest that the regulation of VEGF expression occurs primarily at a
post-transcriptional level.
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(IKK), and mitogen-activated protein kinase (MAPK)
(21).
Vascular endothelial growth factor (VEGF) is a strong
inducer of angiogenesis and is synthesized by macroph-
ages, smooth muscle cells, pericytes, keratinocytes, and
several tumor cells (22). It activates endothelial cells and
induces angiogenesis during inflammation and wound
healing processes (23). The angiogenic activity attributed
to VEGF is also a result its ability to enhance endothelial
cell survival by inducing expression of the anti-apoptotic
protein Bcl-2 (24). Vascular endothelial growth factor
enhances the permeability of blood vessels (25), which is
an important vascular change observed during pulpitis.
It has recently been found in the dentin matrix and its
release during caries progression might contribute to the
reparative response of pulp–dentinal complex (26).
Bacterial LPS enhances VEGF expression by a mixed
population of dental pulp cells in vitro (27) and a recent
paper analysed the expression of VEGF in both healthy
and inflamed dental pulps in vivo (28). However, it is not
known if LPS stimulation has a direct effect on VEGF
expression by odontoblasts or undifferentiated pulp cells.
The purpose of this in vitro study was to evaluate the
effect of bacterial LPS on VEGF expression in mouse
odontoblast-like cells and undifferentiated pulp cells, and
to compare it with two well-characterized cellular
sources of VEGF, namely macrophages and fibroblasts.
The test hypothesis was that all cells increase VEGF
expression following exposure to LPS.
Material and methods
Cell culture
Four mouse cell lines were used in this study: odontoblast-
like cells (MDPC-23), undifferentiated pulp cells (OD-21)
(29), macrophages (RAW 267.4; ATCC, Manassas, VA,
USA), and gingival fibroblasts. The gingival fibroblasts
were primary cells isolated with surgical biopsy from mouse
gingiva, trypsinized and cultured in T-25 flasks. The isola-
tion of cells and animal care were performed in accordance
with institutional guidelines. Cell lines were cultured with
Dulbecco’s Modified Eagle’s medium (DMEM; Gibco
BRL, Grand Island, NY, USA), supplemented with 10%
fetal bovine serum (Gibco), 200 mm l-glutamine (Gibco),
50-units ml)1 penicillin (Gibco), and 50 lg ml)1 strepto-
mycin (Gibco) in a humidified CO2 incubator at 37C.
Enzyme-linked immunosorbent assay
An enzyme linked immunosorbent assay (ELISA) kit
(Quantikine Murine VEGF Kit; R & D Systems, Minnea-
polis, MN, USA) was used to evaluate the concentration of
VEGF (VEGF120 and VEGF164 isoforms) in the condi-
tioned medium collected from each experimental group
after a 24-h exposure to Escherichia coli 055:B5 LPS (Sigma
Chemical Co., St. Louis, MO, USA), or to Prevotella
intermedia LPS (gift from C. E. Shelburne, University of
Michigan, Ann Arbor, MI, USA). Cells were plated in
12-well plates (4 · 104 cells per well) and allowed to attach
overnight. Cell culture medium was changed, and
0–20 lg ml)1 of E. coli LPS or 0–80 lg ml)1 P. intermedia
LPS were added to the medium1 . Conditioned medium was
collected after 24 h, from 3 wells per condition, and the
concentration of VEGF was analysed by ELISA. Recom-
binant mouse VEGF (R &D Systems) was used as a positive
control. Culture medium alone was used to determine
background VEGF expression. The optical density of the
samples were measured in a spectrophotometer at 450 nm
(DU-20; Beckman, Fullerton, CA, USA). The data on
VEGF concentration was normalized by the number of
viable cells at the time of collection of conditioned medium
as determined by Trypan Blue assay (30). Data presented
here describe the results of one representative experiment
selected from at least three independent experiments per
condition and cell type.
Semi-quantitative reverse transcriptase polymerase
chain reaction
The MDPC-23, OD-21, gingival fibroblasts, or macroph-
ages were exposed for 24 h to 0 or 20 lg ml)1 E. coli LPS,
and RNAeasy Mini Kit (Qiagen, Valencia, CA, USA) was
used according to the manufacturer’s instructions to extract
total RNA. Superscript one-step reverse transcriptase
polymerase chain reaction (RT-PCR) with Platinum Taq
(Invitrogen, Carlsbad, CA, USA) was used for cDNA syn-
thesis and PCR amplification, according to manufacturer’s
instructions. Briefly, cDNA synthesis and predenaturation
were achieved by incubating template RNA (10 ng per
sample), 0.2 lm sense primer, 0.2 lm antisense primer,
0.2 lm dNTP, 1.2 mm MgSO4, and 1 ll RT/Platinum Taq
Mix in a reaction volume of 50 ll for 30 min at 50C, then
for 2 min at 94C in a Mastercycler Gradient thermocycler
(Eppendorf, Hamburg, Germany). Polymerase chain reac-
tion amplification was performed at 94C for 15 s, 55C for
30 s, and 72C for 30 s, for 35 cycles. Final extension of
PCR products was achieved by incubation for 5 min at
72C. The PCR was performed using primers designed to
amplify all three mouse VEGF isoforms (i.e. VEGF120,
VEGF164, and VEGF188), with an expected product size for
each isoform of 431, 563, and 635 bp, respectively (31, 32).
The VEGF primers were: sense, 5¢-CTGCTCTCTTGGG-
TCCACTGG-3¢; and antisense, 5¢-CACCGGGTTGGC-
TTGTCACAT-3¢ (32). A housekeeping gene, glyceraldehyde
adenosine-phosphate dehydrogenase (GAPDH), was used as
an amplification internal control for theRT-PCR assays. The
GADPH primers were: sense, 5¢-CCCACTAACATCAAA-
TGGGG-3¢; and antisense, 5¢-TTGGCTCCACCACCCTT-
CAAGT-3¢. Amplification conditions were optimized for this
experiment to determine concentration of template RNA,
number of cycles, and denaturation, annealing, and extension
temperature that allowed for gene expression analysis within
the linear phase of product amplification. The RT-PCR
productswere analysed by electrophoresis on 1%agarose gels
stainedwith ethidium bromide.Gels were photographedwith
aPolaroidgel cameraonanultraviolet transilluminatorscreen
(Spectroline, Westbury, NY, USA). Data presented is repre-
sentative of three independent experiments.
Statistical analyses
Data was analysed by one-way anova followed by Tukey’s
test, or Student’s t-tests with sigmastat 2.0 statistical soft-
ware (SPSS, Chicago, IL, USA). The significance level of the
data was determined at P £ 0.05.
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Results
Lipopolysaccharide upregulates VEGF expression
in odontoblast-like cells and macrophages
To evaluate baseline VEGF expression by pulp cells, we
performed ELISAs of conditioned medium collected
from untreated MDPC-23 or OD-21, and compared
these with expression of VEGF in conditioned medium
from our control cells, fibroblasts and macrophages. We
observed that OD-21 expressed the highest baseline levels
of VEGF, followed by MDPC-23, fibroblasts and
macrophages (Fig. 1). To evaluate the effect of LPS on
VEGF expression in pulp cells, we exposed MDPC-23,
OD-21, fibroblasts or macrophages to 0–20 lg ml)1
E. coli LPS for 24 h, collected the supernatant and per-
formed ELISA. The Trypan Blue exclusion viability test
was used to normalize the data by the number of viable
cells per sample. Exposure to 20 lg ml)1 E. coli LPS
induced upregulation of VEGF expression in MDPC-23
(474.6 ± 88.9 pg ml)1) compared with the untreated
MDPC-23 controls (300 ± 17.5 pg ml)1) (Fig. 2A). In
macrophages, the expression of VEGF was tenfold
higher in cells exposed to 20 lg ml)1 E. coli LPS than in
untreated controls (Fig. 2B). In contrast, we did not find
any induction of VEGF expression upon exposure of
fibroblasts or OD-21 to E. coli LPS (Fig. 2C,D).
Prevotella intermedia is considered one of the predom-
inant bacterial species in dentinal caries (10). To evaluate
the effect of this Gram-negative species on VEGF ex-
pression, we exposed the cells described above to 0–
80 lg ml)1P. intermediaLPS and performedELISA from
conditionedmedium.We observed thatP. intermediaLPS
induced VEGF upregulation inMDPC-23, but only when
Fig. 1. Baseline vascular endothelial growth factor (VEGF)
expression analysed by enzyme-linked immunosorbent assay
(ELISA) of conditioned medium collected from untreated
macrophages, gingival fibroblasts, MDPC-23 or OD-21. Pos-
itive control for ELISA was recombinant mouse VEGF.
Fig. 2. Escherichia coli lipopolysaccharide (LPS) induces vascular endothelial growth factor (VEGF) expression in odontoblast-like
cells (MDPC-23) and macrophages. Expression of VEGF was analysed by enzyme-linked immunosorbent assay (ELISA) of con-
ditioned medium from (A) MDPC-23, (B) macrophages, (C) OD-21, or (D) gingival fibroblasts exposed for 24 h to 0–20 lg ml)1
E. coli LPS. Positive control for ELISA was recombinant mouse VEGF. *, P £ 0.05.
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cells were exposed to at least 60 lg ml)1 LPS (Fig. 3A).
We also observed a tendency towards upregulation of
VEGF expression in macrophages exposed to P. inter-
media LPS (Fig. 3B). In contrast, we did not observe any
upregulation of VEGF expression in OD-21 (Fig. 3C) or
fibroblasts (Fig. 3D) stimulated with P. intermedia LPS.
Lipopolysaccharide-induced VEGF expression
is regulated at post-transcriptional level
To examine if LPS-induced VEGF expression is regula-
ted primarily at the transcriptional or at the post-
transcriptional level, we performed semiquantitative
RT-PCR analysis. The PCR primers used here were
designed to amplify all three mouse VEGF isoforms (32).
However, we only observed bands for the VEGF120 and
VEGF164 isoforms in the cells evaluated in our study.
These findings might be explained by the fact that these
two are the most predominant VEGF isoforms in mice
(31). We observed that the VEGF mRNA expression
is lower in macrophages compared with MDPC-23,
OD-21, or fibroblasts (Fig. 4). Interestingly, E. coli LPS
did not induce any significant change in VEGF expres-
sion at the mRNA level in the cell lines evacuated here
(Fig. 4).
Macrophages exposed to LPS present cytoplasmic
elongations
Macrophage stimulation with P. intermedia LPS
(Fig. 5B) or E. coli LPS (data not shown) induced con-
sistent changes in cell morphology. The majority of the
macrophages became enlarged with short cytoplasmic
elongations, suggesting a process of cellular activation
mediated by LPS (Fig. 5A,B). In contrast, fibroblasts
(Fig. 5C,D), MDPC-23 (Fig. 5E,F), and OD-21
(Fig. 5G,H) did not show any detectable change in
morphology compared with untreated cells when exam-
ined by phase contrast microscopy at ·400.
Fig. 3. Prevotella intermedia lipopolysaccharide (LPS) induces vascular endothelial growth factor (VEGF) expression in odonto-
blast-like cells (MDPC-23) and macrophages. Expression of VEGF was analysed by enzyme-linked immunosorbent assay (ELISA) of
conditioned medium from (A) MDPC-23, (B) macrophages, (C) OD-21, or (D) gingival fibroblasts exposed for 24 h to 0–80 lg ml)1
of P. intermedia LPS. Positive control for ELISA was recombinant mouse VEGF. *, P £ 0.05.
Fig. 4. Vascular endothelial growth factor (VEGF) mRNA
expression is not affected by lipopolysaccharide (LPS) stimu-
lation. Reverse transcriptase polymerase chain reaction
(RT-PCR) for VEGF performed on MDPC-23, OD-21, gingi-
val fibroblasts and macrophages exposed for 24 h to 0 or
20 lg ml)1 Escherichia coli LPS. Glyceraldehyde adenosine-
phosphate dehydrogenase (GAPDH) was used as internal
control for RT-PCR assay.
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Discussion
Vascular endothelial growth factor is one of the major
regulators of neovascular responses throughout the body,
but its function in the dental pulp is still largely unknown.
This study was designed to investigate the relative levels of
VEGF synthesis in MDPC-23, OD-21, gingival fibro-
blasts, and macrophages exposed to LPS, and to provide
insights into the mechanism involved in LPS-induced
VEGF expression in these cells.We observed thatMDPC-
23 and macrophages showed upregulation of VEGF
expression upon stimulation with LPS. In contrast, LPS
did not enhance VEGF expression in mouse OD-21 cells
or in gingival fibroblasts. A comparative analysis of
RT-PCR and ELISA data suggested that VEGF is regu-
lated primarily at the post-transcriptional level.
The odontoblast-like cells (MDPC-23) and undiffer-
entiated pulp cells (OD-21) used in this study were cells
spontaneously immortalized from CD)1 fetal mouse
molar papillae (33). The MDPC-23 cells express dentin
phosphophoryn (DPP) and dentin sialoprotein (DSP),
while OD-21 cells do not express these markers of
odontoblastic activity (33). We believe that an important
finding of our study is the high baseline level of VEGF
expression observed in untreated odontoblast-like cells
and undifferentiated pulp cells. Untreated MDPC-23 and
OD-21 expressed, respectively, approximately 14 and 25
times more VEGF than untreated macrophages. The
relevance of this observation is perhaps demonstrated by
the fact that macrophages are considered to be key
orchestrators of neovascularization during wound heal-
ing and several angiogenesis-dependent diseases (34).
The presence of capillary loops in secreting odontoblast
layers provides access of nutrients and minerals to the
calcifying front and allows for the deposition of secon-
dary dentin (35, 36). Interestingly, our in vitro findings
are in agreement with a previous report that showed
expression of VEGF in healthy pulps of non-carious
teeth without signs of inflammation by immunohisto-
chemistry (28). Furthermore, our data suggest that
odontoblasts and undifferentiated pulp cells are import-
ant cellular sources of VEGF in the dental pulp. We
speculate that the relatively high levels of VEGF secreted
by unstimulated pulp cells provide a pro-angiogenic
input that is necessary for the maintenance of pulp vas-
cularization.
The expression of VEGF in the dentin matrix reported
recently by Roberts-Clark & Smith (26) suggests
that VEGF was also present during dentinogenesis.
Importantly, the authors propose that the dentin matrix
VEGF could be released during caries progression and
contribute to reparative responses of the dentin–pulp
complex. Here, we identified the odontoblasts and
macrophages as additional sources of the VEGF that
might be involved in the orchestration of the pro-angi-
ogenic responses observed in the pulp of carious teeth.
We observed that odontoblast-like cells and macroph-
ages, but not undifferentiated pulp cells, exposed to
bacterial LPS consistently upregulate VEGF synthesis.
While the results obtained from cell lines should be
interpreted with caution, our experiments confirmed a
previous report that demonstrated that VEGF was
up-regulated in a mixed population of human dental
pulp cells exposed to LPS (27), and suggest that odon-
toblasts and macrophages may be the cell populations
responsible, in part, for the previously reported upregu-
lation of VEGF expression induced by LPS.
The observation that odontoblast-like cells stimulated
by LPS upregulate VEGF expression suggests a novel
role for odontoblasts in pulp biology, i.e. regulation of
pulpal angiogenesis. Odontoblasts are considered to be
one of the first cell populations to sense the bacterial
challenge that occurs during the progress of dentinal
caries (1). We propose that upregulated VEGF synthesis
by odontoblasts stimulated with LPS might have two
functions. (a) To increase the permeability of existing
pulp blood vessels. VEGF-induced microvessel per-
meability is known to facilitate the process of diapedesis
of neutrophils, lymphocytes, and monocytes (25). This
would allow for the establishment of cellular defenses to
protect the pulp tissue against the bacterial challenges
resulting from caries progression. (b) To recruit new
blood vessels to the area closest to the carious lesion.
This would enhance the access of the blood-derived
antibodies and defense cells to protect the pulp tissue
against bacterial challenges (3, 37).








Fig. 5. Macrophages exposed to lipopolysaccharide (LPS) present cytoplasmic elongations. Micromorphology of (A,B) macr-
ophages, (C,D) gingival fibroblasts, (E,F) MDPC-23, and (G,H) OD-21, exposed for 24 h to 0 or 80 lg ml)1 Prevotella Intermedia
LPS. Phase-contrast photomicrographs at ·400.
232 Botero et al.
Macrophages exposed to bacterial LPS also showed
upregulation in VEGF expression. The VEGF upregu-
lation in macrophages exposed to bacterial LPS reported
here corroborates findings published elsewhere (38–40)
and are in agreement with the observation that VEGF is
strongly expressed in cells of the inflammatory infiltrate
of teeth with irreversible pulpitis (28). Macrophages
challenged with bacterial LPS were enlarged and pre-
sented short cytoplasmic elongations compared with
smaller and round, untreated macrophages. These mor-
phological changes might be correlated with the complex
process of macrophage activation observed upon stimu-
lation by bacterial products (41).
Prevotella intermedia have been associated with the
process of dentinal caries (10), irreversible pulpitis (12),
and endodontic infections (42,43). The data presented
here showed that P. intermedia LPS induced a similar
trend of VEGF induction to E. coli LPS, but it required
higher concentrations of LPS. In the current study,
0–20 lg ml)1 E. coli LPS or 0–80 lg ml)1 P. intermedia
LPS were used to challenge the cells. Other studies have
used a range of 0.01–100 lg ml)1 LPS (27,44), which is
believed to be within a range of LPS relevant to pulp
pathologies (45). A previous investigation has evaluated
the effect of LPS from Porphyromonas endodontalis,
Porphyromonas gingivalis, Fusobacterium nucleatum, and
E. coli on DNA content, protein synthesis, and alkaline
phosphatase activity in dental pulp cells (44). The
authors found a similar trend for the effect of LPS from
these bacterial species on DNA content and protein
synthesis, however, E. coli LPS seemed to elicit the most
intense responses (44). We speculate that the differences
in reactivity between E. coli and P. intermedia LPS might
arise from their molecular specificity to cell receptors, or
differences in the chemical structure of the lipid A por-
tion of the LPS molecule, which has been shown to affect
the intensity of responses in other systems (17,46).
Baseline VEGF mRNA expression was lowest in
macrophages, which was in agreement with our ELISA
data. Interestingly, there were no significant changes in
VEGF mRNA levels, compared with untreated control
cells, when MDPC-23 or macrophages were exposed to
LPS. It was previously reported that VEGF regulation
occurs primarily at the level of mRNA stability, since
ubiquitination of its 3¢UTR is impaired when proangi-
ogenic stimuli are present (47). Our data corroborate the
study that was performed in rat heart myocytes (47) and
indicate that the regulation of LPS-induced VEGF
expression in MDPC-23 and macrophages also happens
primarily at the post-transcriptional level.
In summary, the data presented here demonstrates
that non-stimulated mouse dental pulp cells secrete high
levels of the pro-angiogenic VEGF protein. Interestingly,
the odontoblast-like cells and macrophages, but not
undifferentiated pulp cells or fibroblasts, upregulated
VEGF protein expression in response to LPS stimula-
tion. This demonstrates that the ability to respond to
LPS stimulation and enhance VEGF expression is spe-
cific to certain cell types, and not a generalized cellular
response. The results require rejection of the test hypo-
thesis that all cells increase VEGF expression following
exposure to LPS. We hypothesize that odontoblasts and
macrophages are key orchestrators of pulp neovascu-
larization in teeth with deep carious lesions. In vivo
models of pulp angiogenesis are currently being used to
test this hypothesis.
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